Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers

Fig. 1

Kaplan–Meier plot (a) and Cox regression analysis (b) of time to first adjudicated MACE. Cox proportional hazards model with baseline CV risk group, smoking status, treatment group and baseline beta-blocker use as factors. Interaction P = 0.48. CI confidence interval, CV cardiovascular, HR hazard ratio, MACE major adverse cardiovascular event, N total number of patients, n total number of patients experiencing event

Back to article page